Different frequencies should be prescribed for different high frequency chest compression machines

Area of Science:

• Pulmonology
• Respiratory Therapy
• Biomedical Engineering

Background:

• High frequency chest compression (HFCC) is a non-invasive method for airway clearance in patients with lung diseases.
• HFCC devices aim to improve mucus mobilization and reduce the risk of respiratory infections like bronchitis and pneumonia.
• Treatment effectiveness can be influenced by prescribed frequencies, which may follow generic guidelines or patient-specific tuning.

Purpose of the Study:

• To investigate the efficacy of a "tuning" method for determining optimal High Frequency Chest Compression (HFCC) frequencies.
• To analyze the variability of optimal HFCC frequencies across individual patients and different HFCC machine waveforms (sine vs. square).
• To establish a basis for a recommended tuning protocol for prescribing HFCC frequencies.

Main Methods:

• A tuning method was employed, measuring air volume displacement and airflow at the mouth across a range of frequencies (6-25 Hz) during normal breathing.
• HFCC flow velocities and volumes were computed and averaged for each frequency, with data digitized and analyzed.
• The top three frequencies for highest flow and largest volume were identified, with adjustments made if a frequency ranked in both categories.

Main Results:

• Optimal HFCC frequencies varied significantly between individual cystic fibrosis patients and did not correlate with demographic or spirometry data.
• For sine waveform machines, peak airflow was typically achieved between 13-20 Hz, while peak volume occurred between 6-10 Hz.
• For square waveform machines, both peak airflow and volume were generally observed between 6-14 Hz; however, all tested frequencies (6-20 Hz) proved optimal for at least one patient.

Conclusions:

• Patient-specific tuning is crucial for optimizing High Frequency Chest Compression (HFCC) therapy, as generic guidelines or machine defaults may not be universally effective.
• Significant inter-patient variability necessitates individualized frequency selection for HFCC treatment, highlighting the importance of the tuning protocol.
• The findings support the development of a standardized tuning protocol for prescribing HFCC frequencies, especially when individual tuning is not feasible.